Analysts Set DocuSign, Inc. (NASDAQ:DOCU) PT at $92.45

Shares of DocuSign, Inc. (NASDAQ:DOCUGet Free Report) have been assigned an average rating of “Hold” from the thirteen ratings firms that are presently covering the stock, MarketBeat.com reports. Three research analysts have rated the stock with a sell recommendation, seven have given a hold recommendation and three have given a buy recommendation to the company. The average 1-year target price among analysts that have covered the stock in the last year is $92.45.

DOCU has been the subject of several research reports. Royal Bank of Canada reissued a “sector perform” rating and set a $90.00 price objective (up previously from $57.00) on shares of DocuSign in a report on Friday, December 6th. JMP Securities reaffirmed a “market outperform” rating and set a $124.00 price target on shares of DocuSign in a research note on Tuesday, January 7th. Morgan Stanley increased their target price on DocuSign from $62.00 to $97.00 and gave the stock an “equal weight” rating in a research note on Friday, December 6th. UBS Group lifted their price target on shares of DocuSign from $60.00 to $100.00 and gave the company a “neutral” rating in a research note on Friday, December 6th. Finally, Wells Fargo & Company increased their target price on shares of DocuSign from $50.00 to $70.00 and gave the stock an “underweight” rating in a report on Friday, December 6th.

Check Out Our Latest Research Report on DocuSign

Insider Transactions at DocuSign

In other news, CEO Allan C. Thygesen sold 7,763 shares of DocuSign stock in a transaction on Monday, December 2nd. The stock was sold at an average price of $80.54, for a total value of $625,232.02. Following the completion of the sale, the chief executive officer now owns 100,062 shares of the company’s stock, valued at $8,058,993.48. The trade was a 7.20 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Daniel D. Springer sold 581,588 shares of the stock in a transaction that occurred on Tuesday, December 10th. The stock was sold at an average price of $97.04, for a total transaction of $56,437,299.52. Following the transaction, the director now directly owns 906,430 shares in the company, valued at approximately $87,959,967.20. This represents a 39.08 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 685,773 shares of company stock valued at $66,032,726 in the last ninety days. Corporate insiders own 1.66% of the company’s stock.

Institutional Inflows and Outflows

Institutional investors have recently modified their holdings of the business. Itau Unibanco Holding S.A. bought a new position in shares of DocuSign in the 3rd quarter worth about $28,000. Kestra Investment Management LLC acquired a new stake in shares of DocuSign in the 4th quarter worth approximately $30,000. Brooklyn Investment Group acquired a new position in shares of DocuSign during the 3rd quarter valued at $33,000. Modus Advisors LLC acquired a new position in DocuSign during the fourth quarter worth about $36,000. Finally, First Horizon Advisors Inc. raised its holdings in shares of DocuSign by 102.6% in the 4th quarter. First Horizon Advisors Inc. now owns 397 shares of the company’s stock worth $36,000 after purchasing an additional 201 shares in the last quarter. Institutional investors and hedge funds own 77.64% of the company’s stock.

DocuSign Trading Up 0.4 %

DOCU opened at $90.86 on Tuesday. The company has a market capitalization of $18.36 billion, a PE ratio of 18.73, a PEG ratio of 7.56 and a beta of 0.89. The firm’s 50 day simple moving average is $92.58 and its two-hundred day simple moving average is $74.47. DocuSign has a 1-year low of $48.70 and a 1-year high of $107.86.

DocuSign Company Profile

(Get Free Report

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.

Further Reading

Analyst Recommendations for DocuSign (NASDAQ:DOCU)

Receive News & Ratings for DocuSign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocuSign and related companies with MarketBeat.com's FREE daily email newsletter.